Sherman Asset Management, Inc.
Source: SEC Form 13F · as of Mar 2026Sherman Asset Management, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $2.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$2.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 865 | $796K |
| JNJJOHNSON & JOHNSON | 1,466 | $358K |
| GILDGILEAD SCIENCES, INC. | 1,920 | $268K |
| AMGNAMGEN INC | 695 | $245K |
| MRKMerck & Co., Inc. | 1,708 | $205K |
| BMYBRISTOL MYERS SQUIBB CO | 2,849 | $173K |
| ABTABBOTT LABORATORIES | 1,418 | $146K |
| PFEPFIZER INC | 4,833 | $136K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 260 | $70K |
| CYTKCYTOKINETICS INC | 142 | $9K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 15 | $5K |
| GMOptec International, Inc. | 40 | $3K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.